- Home
- CTMX vs IAE Comparison
CTMX vs IAE Comparison
Compare CTMX & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- IAE
- Stock Information
- Founded
- CTMX 2008
- IAE 2007
- Country
- CTMX United States
- IAE United States
- Employees
- CTMX N/A
- IAE N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- CTMX Health Care
- IAE Finance
- Exchange
- CTMX Nasdaq
- IAE Nasdaq
- Market Cap
- CTMX 62.3M
- IAE 69.8M
- IPO Year
- CTMX 2015
- IAE N/A
- Fundamental
- Price
- CTMX $0.59
- IAE $6.12
- Analyst Decision
- CTMX Buy
- IAE
- Analyst Count
- CTMX 6
- IAE 0
- Target Price
- CTMX $5.77
- IAE N/A
- AVG Volume (30 Days)
- CTMX 3.8M
- IAE 46.3K
- Earning Date
- CTMX 03-06-2025
- IAE 01-01-0001
- Dividend Yield
- CTMX N/A
- IAE 10.21%
- EPS Growth
- CTMX N/A
- IAE N/A
- EPS
- CTMX 0.38
- IAE N/A
- Revenue
- CTMX $138,103,000.00
- IAE N/A
- Revenue This Year
- CTMX N/A
- IAE N/A
- Revenue Next Year
- CTMX N/A
- IAE N/A
- P/E Ratio
- CTMX $1.57
- IAE N/A
- Revenue Growth
- CTMX 36.45
- IAE N/A
- 52 Week Low
- CTMX $0.56
- IAE $5.31
- 52 Week High
- CTMX $5.85
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- CTMX 43.41
- IAE 43.59
- Support Level
- CTMX $0.57
- IAE $6.12
- Resistance Level
- CTMX $0.65
- IAE $6.26
- Average True Range (ATR)
- CTMX 0.05
- IAE 0.07
- MACD
- CTMX 0.01
- IAE -0.00
- Stochastic Oscillator
- CTMX 51.28
- IAE 28.26
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.